SGC agonist 2
Modify Date: 2025-08-27 16:27:05
SGC agonist 2 structure
|
Common Name | SGC agonist 2 | ||
|---|---|---|---|---|
| CAS Number | 2735713-77-4 | Molecular Weight | 461.42 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H17F2N7O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SGC agonist 2SGC agonist 2 is a potent agonist of soluble guanylate cyclase (SGC). Soluble guanylate cyclase is a key signal transduction enzyme in the NO-sGC-cGMP signaling pathway. SGC agonist 2 has the potential for the research of cardiovascular disease (heart failure, pulmonary hypertension, angina, myocardial infarction) and fibrotic diseases (renal fibrosis, systemic sclerosis) (extracted from patent WO2021219088A1, compound 031)[1]. |
| Name | SGC agonist 2 |
|---|
| Description | SGC agonist 2 is a potent agonist of soluble guanylate cyclase (SGC). Soluble guanylate cyclase is a key signal transduction enzyme in the NO-sGC-cGMP signaling pathway. SGC agonist 2 has the potential for the research of cardiovascular disease (heart failure, pulmonary hypertension, angina, myocardial infarction) and fibrotic diseases (renal fibrosis, systemic sclerosis) (extracted from patent WO2021219088A1, compound 031)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Fuyu Luo, et al. Pyrimidine tricyclic compounds and their applications. Patent WO2021219088A1. |
| Molecular Formula | C23H17F2N7O2 |
|---|---|
| Molecular Weight | 461.42 |